ImmunoPrecise Antibodies Ltd. (IPA) Financials
Stock symbol IPA is outdated, potentially delisted? Maybe it is available on other exchange?
IPA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| April 30, 2025 | 32.2 million | 15.1 million |
| Jan. 31, 2025 | 31.4 million | 14.1 million |
| Oct. 31, 2024 | 43.1 million | 19.6 million |
| July 31, 2024 | 42.9 million | 19.1 million |
IPA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| April 30, 2025 | -1.1 million | 38431 |
| Jan. 31, 2025 | -907688 | 48318 |
| Oct. 31, 2024 | -1.7 million | 112761 |
| July 31, 2024 | -1.5 million | 119239 |
IPA Net Income
No data available :(
IPA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| April 30, 2025 | 7.7 million | 8.4 million | 9.7 million |
| Jan. 31, 2025 | 8.9 million | 7.8 million | 8.9 million |
| Oct. 31, 2024 | 2.5 million | 8.4 million | 9.6 million |
| July 31, 2024 | 2.8 million | 8.6 million | 9.8 million |
IPA Shares Outstanding
IPA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| April 30, 2025 | 260315 | 789648 | 3.4 million | 749041 |
| Jan. 31, 2025 | 77308 | 729602 | 3.4 million | 904237 |
| Oct. 31, 2024 | 46684 | 829550 | 3.2 million | 888445 |
| July 31, 2024 | 190060 | 1.2 million | 3.4 million | 518872 |
IPA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| April 30, 2025 | 5.1 million | 1.8 million |
| Jan. 31, 2025 | 4.2 million | 2.0 million |
| Oct. 31, 2024 | 4.4 million | 1.9 million |
| July 31, 2024 | 3.8 million | 2.1 million |
IPA
Price: $1.55
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.66 USD
P/E Ratio: -3.14
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 28913
Market Capitalization: 95.5 million